Aethlon Medical, Inc. (AEMD) vs FibroBiologics, Inc. Common Stock (FBLG)

A side-by-side comparison of Aethlon Medical, Inc. and FibroBiologics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Aethlon Medical, Inc. logo
AEMD
Aethlon Medical, Inc.
$3M
$6.36HealthcareDelayed quote: Oct 6, 2026, 11:28 AM EDT
FibroBiologics, Inc. Common Stock logo
FBLG
FibroBiologics, Inc. Common Stock
$3M
$1.23HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT

Total return — AEMD vs FBLG

growth of $100 · dividends reinvested · last 3y
AEMD -99.1% (-79.0%/yr)FBLG -99.8% (-87.3%/yr)AEMD compounded faster over this window
020406080100Start $10020252026$1$0
AEMD FBLG

AEMD vs FBLG: by the numbers

  • •AEMD is the larger company ($3M vs $3M market cap).

Metrics side by side

Valuation

MetricAEMDFBLG
P/B ratio0.640.56

Profitability

MetricAEMDFBLG
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-133.43%-391.26%
ROIC-133.29%-286.46%

Growth (annualized)

MetricAEMDFBLG
Total return CAGR (5Y)-78.27%N/A

Go deeper

Full AEMD analysisFull FBLG analysisInteractive comparison tool

Dig into the metrics

Aethlon Medical ROEFibroBiologics, Inc. Common Stock ROEAethlon Medical operating marginFibroBiologics, Inc. Common Stock operating marginAethlon Medical revenue growthFibroBiologics, Inc. Common Stock revenue growthAethlon Medical free cash flowFibroBiologics, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.